Evidence map›Paper›PMID 41028679›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Characterization and Phenotypic Assessment of Zebrafish Disease Models for Splice Modulation Studies.

Holly R Thomas, Katherine G English, Matthew S Alexander, John M Parant

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Holly R ThomasDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Katherine G EnglishDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA.
Matthew S AlexanderDepartment of Pediatrics, Division of Neurology at Children's of Alabama and the University of Alabama at Birmingham, Birmingham, AL, USA. matthewalexander@uabmc.edu.
John M ParantDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA. jparant@uab.edu.

Funding

UAB Pilot Center for Precision Animal Modeling (C-PAM) - Resource and Service SectionU54OD030167 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Elizabeth A Worthey · 2020 to 2026
$15.3M
Deciphering How Esco2 Loss Acts as a Penetrance ModifierR01CA216108 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PARANT, JOHN M · 2017 to 2021
$1.9M
Dystrophin as a novel regulator of the circadian clock in skeletal muscle and the brainR21NS140497 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MATTHEW Scott ALEXANDER · 2025 to 2026
$424k
NCI NIH HHS R01 CA216108NIH HHS U54 OD030167NINDS NIH HHS R21 NS140497
6 · The paper itself

Abstract

Zebrafish has emerged as a powerful model in biomedical research as it recapitulates many human disease pathologies. Zebrafish share approximately 70% evolutionarily conserved genes with humans. Recent advances in genome editing have enabled many precision and inducible models that mimic human disorders to be rapidly generated for phenotypic analysis. The large clutch size, ex vivo development, and ability to uptake drug compounds through their skin and gills during early larvae development make the zebrafish an extremely attractive system for high-throughput drug screening. Here, we describe the generation of zebrafish models for splice modulation studies and general phenotypic assessments in human disease modeling.

Indexed as

Disease Models, AnimalRNA SplicingZebrafishAnimalsGene EditingHumansPhenotypeAssessmentsCRISPRFunctionalityPhenotypeRNA splice modulationZebrafish

Identifiers

PMID41028679
PMCPMC12797569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.